GILEAD SCIENCES INC (GILD) Stock News
NASDAQ:GILD - Nasdaq - US3755581036 - Common Stock - Currency: USD
GILD Latest News, Press Relases and Analysis
Market Monitor May 7 ( Hims & Hers Health, Upwork UP - Palantir, Monderna DOWN)
Wall Street Retreats as Pharma Stocks Tumble and Trade Uncertainty Lingers
GILEAD SCIENCES INC (NASDAQ:GILD) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
When you look at GILEAD SCIENCES INC (NASDAQ:GILD), it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
Drugmaker Gilead pledges $11 billion investment in U.S. manufacturing
Marjorie Taylor Greene Goes Stock Shopping Again: Here Are 50+ Stocks The Congresswoman Bought
Marjorie Taylor Greene disclosed buying more than 50 stocks in early May. A look at the list and why the congresswoman's past trades have drawn red flags.
S&P 500 snaps 9-session winning streak, closes down 0.6%
Markets stumbled again on Monday after an extended rally from the selloff incurred by Trump's tariffs.
1 Profitable Stock on Our Watchlist and 2 to Turn Down
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
Interesting Technical Analysis finding for GILEAD SCIENCES INC (NASDAQ:GILD)
Exploring GILEAD SCIENCES INC's Technical Signals and Breakout Potential: Based on good technical signals, GILEAD SCIENCES INC is potentially setting up for a breakout.
3 Biotech Giants Gaining From U.S. Sales and Policy Shifts
The significant domestic revenue base of select US biotech companies offers stability potential for investors navigating global trade complexities.
Struggling Peninsula biotech with Gilead lineage is latest purchase for activist investor
Should You Buy, Sell or Hold GILD Stock Post Q1 Earnings Miss?
GILD is trading down after disappointing first-quarter results. While the fundamentals look solid in the long run, the oncology business is under pressure. We advise investors to remain on the sidelines at current levels.
Is Most-Watched Stock Gilead Sciences, Inc. (GILD) Worth Betting on Now?
Gilead (GILD) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
These 3 Funds Offer Sky-High Yields of 15% or More and Trade at a Discount
Moderna (MRNA) Reports Earnings Tomorrow: What To Expect
Biotechnology company Moderna (NASDAQ:MRNA) will be announcing earnings results tomorrow before market hours. Here’s what you need to know.
Gilead Sciences to Present at Upcoming Investor Conferences
Gilead Sciences Agrees to Pay $202 Million Over Doctor Payments
Gilead Sciences Inc. reached a $202 settlement with the US to resolve claims that it paid doctors and gave them meals and travel expenses for events to get them to prescribe its drugs.
Gilead to Present Latest Advancements Across Primary Biliary Cholangitis and Viral Hepatitis
S&P 500 Gains and Losses Today: AbbVie Stock Advances After Beat-and-Raise Earnings Report
The S&P 500 edged 0.1% higher on Monday, April 28, eking out a fifth straight winning session to kick off a week of key earnings reports and economic data releases.
These S&P500 stocks are moving in today's session
Curious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session.
Exploring the top movers within the S&P500 index during today's session.
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Monday as we examine the latest happenings in today's session.
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
Get insights into the top movers in the S&P500 index of Friday's pre-market session.
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
Which S&P500 stocks are moving after the closing bell on Thursday?
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top S&P500 gainers and losers driving the post-market movements.
Why Quality Investors May Find GILEAD SCIENCES INC (NASDAQ:GILD) Attractive.
A fundamental analysis of (NASDAQ:GILD) shows GILEAD SCIENCES INC (NASDAQ:GILD) may be suited for quality investing, we'll explore why in this article.